Company / Return on Equity (ROE)
STANDARD BIOTOOLS INC. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-15.8%
FY2025
5-year range
-201.0% / -15.8%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
STANDARD BIOTOOLS INC. reports negative total equity of -15.8% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-15.8% in FY2025 with a 5-year CAGR of +66.0%.
Improved from -62.6% to -15.8% over the past 3 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +46.8pp
- 5-Year Change
- +66.0pp
- 10-Year Change
- -
Key checks
Key Insights
- Lowest return on equity (roe) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -15.8% | - |
| FY2024 | - | - |
| FY2023 | -201.0% | -220.9% |
| FY2022 | -62.6% | -34.4% |
| FY2021 | -46.6% | +43.1% |
| FY2020 | -81.8% | +58.2% |
| FY2019 | -195.7% | -37.1% |
| FY2018 | -142.7% | -207.6% |
| FY2017 | -46.4% | -32.1% |
| FY2016 | -35.1% | -104.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026